Drug Approval | June 12, 2022
Strides receives USFDA approval for Ibuprofen OTC oral suspension
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
It paves the way for an industry Code of Good Practice
The product will be manufactured at Lupin’s facility in Goa, India
Successful proposals will secure fully funded postdoctoral research positions
The product will be manufactured at Lupin’s facility in Goa, India
Subscribe To Our Newsletter & Stay Updated
